Torrent Pharma vs Mankind Pharma: share price, P/E, ROE and financials compared
Torrent Pharmaceuticals
Mankind Pharma
Torrent Pharma and Mankind Pharma at a glance
Torrent Pharma and Mankind Pharma are both listed in Healthcare. Torrent Pharma is the larger by market cap, at ₹1.8L Cr against ₹1.0L Cr for Mankind Pharma (1.7 times as large). On valuation, Mankind Pharma has the lower P/E (46.8× against 80.2×) and the lower price-to-book (5.97× against 9.83×). On returns and margins, Torrent Pharma has the higher ROE (15.7% against 13.6%) and the higher operating margin (33.7% against 26.5%), while Mankind Pharma has the higher ROCE (13.7% against 9.1%). Over three years, Torrent Pharma has faster 3-year profit growth (+20.2% against +14.3% a year), while Mankind Pharma has faster 3-year sales growth (+17.7% against +13.3% a year). Mankind Pharma carries less debt for its equity, with a debt-to-equity of 0.30× against 0.77×.
Key metrics, side by side
| Metric | Torrent PharmaTORNTPHARM | Mankind PharmaMANKIND |
|---|---|---|
| Price (₹) | 4,750.00 | 2,540.00 |
| Market cap (₹ Cr) | 1,80,675 | 1,04,913 |
| P/E | 80.2× | 46.8× (the lower figure, shaded) |
| P/B | 9.83× | 5.97× (the lower figure, shaded) |
| Dividend yield, trailing | 0.80% (the higher figure, shaded) | 0.00% |
| ROE | 15.7% (the higher figure, shaded) | 13.6% |
| ROCE | 9.1% | 13.7% (the higher figure, shaded) |
| Operating margin (OPM) | 33.7% (the higher figure, shaded) | 26.5% |
| Net margin (NPM) | 12.2% | 14.6% (the higher figure, shaded) |
| Sales CAGR 3Y | +13.3% | +17.7% (the higher figure, shaded) |
| Profit CAGR 3Y | +20.2% (the higher figure, shaded) | +14.3% |
| Debt to equity | 0.77× | 0.30× (the lower figure, shaded) |
| Interest cover | 8.5× (the higher figure, shaded) | 4.7× |
| Net profit TTM (₹ Cr) | 2,124 | 2,243 |
| 1Y return | +31.7% (the higher figure, shaded) | +6.3% |
| Promoter holding | 60.78% | 72.62% |
Torrent Pharma vs Mankind Pharma: common questions
Which is bigger, Torrent Pharma or Mankind Pharma?
By market cap, Torrent Pharma is bigger at ₹1.8L Cr, against ₹1.0L Cr for Mankind Pharma (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹2,124 Cr for Torrent Pharma and ₹2,243 Cr for Mankind Pharma.
Which has a lower P/E ratio, Torrent Pharma or Mankind Pharma?
Torrent Pharma trades at a P/E of 80.2× and Mankind Pharma at 46.8×. Mankind Pharma has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Torrent Pharma or Mankind Pharma?
Torrent Pharma reports a return on equity of 15.7% and Mankind Pharma 13.6%. Torrent Pharma has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Torrent Pharma or Mankind Pharma?
Over the last three years: Sales grew +13.3% a year at Torrent Pharma and +17.7% at Mankind Pharma, so Mankind Pharma grew sales faster; profit grew +20.2% a year at Torrent Pharma and +14.3% at Mankind Pharma, so Torrent Pharma grew profit faster. Past growth doesn’t predict future growth.